Vietnam MOH registration 338383

Qualitative test reagents for CD14 antigen-expressing cells

VN: Thuốc thử xét nghiệm định tính các tế bào biểu hiện kháng nguyên CD14
BD CD14 (MɸP9) FITC
Vietnam flagVietnam·BD CD14 (MɸP9) FITC·Becton Dickinson Caribe, Ltd.; Becton, Dickinson and Company, BD Biosciences·Registered Dec 29, 2022 – Apr 30, 2023Expired
Registration details
Analysis ID
338383
Product Type
BD CD14 (MɸP9) FITC
Product Code
345784
Company information
Manufacturer Country
United States
Product Owner
Becton, Dickinson and Company, BD Biosciences
Owner Country
United States
Technical details
Unit
Lọ
Dates and status
Registration Date
Dec 29, 2022
Expiry Date
Apr 30, 2023
Status
Hết hiệu lực
Pricing
Maximum Selling Price
11088000 VND
Companies making similar products

Companies providing products similar to "Qualitative test reagents for CD14 antigen-expressing cells"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Qualitative test reagents for CD14 antigen-expressing cells in Vietnam's medical device market through Pure Global AI's free database. is registered under number 338383 and manufactured by Becton Dickinson Caribe, Ltd.; Becton, Dickinson and Company, BD Biosciences. The authorized representative in Vietnam is SISC VIETNAM EQUIPMENT JOINT STOCK COMPANY.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Becton Dickinson Caribe, Ltd.; Becton, Dickinson and Company, BD Biosciences, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI300,000+ Devices1 Competitors1 Recent Registrations